Not Yet RecruitingNot Applicable

Generative AI Patient Education Module for Breast Oncology

United States35 participantsStarted 2026-05-01

Plain-language summary

This study evaluates the safety, accuracy, and impact of an artificial intelligence (AI) tool designed to support patient education in breast cancer care for breast oncology patients under selected physicians care within the University of California, San Francisco breast cancer center and affiliate sites.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Females or males ages 18 and over.
✓. Patients must have either:
✓. Stage IV breast cancer facing a treatment change and are expected to have follow-up visits at least once every three months, or
✓. Stage I-III breast cancer diagnosed within the past 6 months.
✓. Basic computer literacy and regular internet access at home.
✓. Able to understand study procedures and to comply with them for the entire length of the study.
✓. Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.

Exclusion criteria

✕. Contraindication to any study-related procedure or assessment.
✕. Cognitive impairment that would interfere with tool usage or survey completion

What they're measuring

Mean score of Safety and Risk Assessment (Lead-in and Provider)

Timeframe: Up to 90 months

Mean score of Provider Assessment of AI patient Education Tool Survey (Provider)

Timeframe: Up to 180 days

Mean score of Assessment of Answer Accuracy and Content Appropriateness (Provider)

Timeframe: Uup to 180 days

Trial details

NCT IDNCT07512271

SponsorUniversity of California, San Francisco

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

Contact for this trial

Ivy Ow

877-827-3222 Ivy.Wong@ucsf.edu

View on ClinicalTrials.gov More Breast Cancer trials